Follow
Parvathy Venugopal
Parvathy Venugopal
Centre for Cancer Biology
Verified email at sa.gov.au
Title
Cited by
Cited by
Year
Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia
U Nekanti, S Dastidar, P Venugopal, S Totey, M Ta
International journal of biological sciences 6 (5), 499, 2010
2292010
Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications
U Nekanti, L Mohanty, P Venugopal, S Balasubramanian, S Totey, M Ta
Stem cell research 5 (3), 244-254, 2010
1702010
Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study
P Swamynathan, P Venugopal, S Kannan, C Thej, U Kolkundar, ...
Stem cell research & therapy 5, 1-17, 2014
1322014
Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow
S Balasubramanian, C Thej, P Venugopal, N Priya, Z Zakaria, ...
Cell biology international 37 (5), 507-515, 2013
802013
Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells
S Balasubramanian, P Venugopal, S Sundarraj, Z Zakaria, AS Majumdar, ...
Cytotherapy 14 (1), 26-33, 2012
652012
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
P Venugopal, S Balasubramanian, AS Majumdar, M Ta
Stem Cells and Cloning: Advances and Applications, 39-50, 2011
652011
Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes
CE Chong, P Venugopal, PH Stokes, YK Lee, PJ Brautigan, DTO Yeung, ...
Leukemia 32 (1), 194-202, 2018
562018
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
CN Hahn, P Venugopal, HS Scott, DK Hiwase
Immunological reviews 263 (1), 257-278, 2015
562015
Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics
Z Hu, HS Scott, G Qin, G Zheng, X Chu, L Xie, DL Adelson, BE Oftedal, ...
Scientific reports 5 (1), 10940, 2015
532015
GATA2 deficiency syndrome: a decade of discovery
CC Homan, P Venugopal, P Arts, NH Shahrin, S Feurstein, L Rawlings, ...
Human Mutation 42 (11), 1399-1421, 2021
352021
Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient
P Venugopal, S Moore, DM Lawrence, AJ George, RD Hannan, SCE Bray, ...
Haematologica 102 (12), e506, 2017
302017
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
C Saygin, G Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ...
Blood Advances 7 (4), 549-554, 2023
262023
A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature
J Kazenwadel, P Venugopal, A Oszmiana, J Toubia, L Arriola-Martinez, ...
Nature 614 (7947), 343-348, 2023
172023
Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia
CN Hahn, PJ Brautigan, CE Chong, A Janssan, P Venugopal, Y Lee, ...
Leukemia 29 (8), 1795-1797, 2015
162015
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
CC Homan, MW Drazer, K Yu, DM Lawrence, J Feng, L Arriola-Martinez, ...
Blood Advances 7 (20), 6092-6107, 2023
122023
Somatic mutational landscape of hereditary hematopoietic malignancies associated with germline variants in RUNX1, GATA2 and DDX41
AL Brown, C Homan, MW Drazer, K Yu, D Lawrence, J Feng, ...
Blood 140 (Supplement 1), 4030-4033, 2022
42022
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
P Venugopal, L Gagliardi, C Forsyth, J Feng, K Phillips, M Babic, ...
BMC Medical Genetics 21, 1-5, 2020
32020
Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features
V Carruthers, M Nicola, P Venugopal, CN Hahn, HS Scott, T Revesz
Journal of paediatrics and child health 53 (10), 1018-1020, 2017
32017
An integrative genomic approach to examine mutations and biological pathways associated with hematological malignancy development in DDX41 mutated families
P Venugopal, JJC Cheah, L Eshraghi, NH Shahrin, C Homan, J Feng, ...
Blood 134, 2686, 2019
22019
Australian Familial Haematological Cancer Study-findings from 15 years of aggregated clinical, genomic and transcriptomic data
CN Hahn, M Babic, PJ Brautigan, P Venugopal, K Phillips, J Dobbins, ...
Blood 134, 1439, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20